OPAL vs REGN · P/E 26, rev $300.0M vs P/E 14, rev $14.34B
OPAL Fuels Inc (OPAL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
OPAL Fuels Inc (OPAL) is a utilities - regulated gas company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported OPAL revenue for 2024-12-31 was $300.0M. Net income was $14.3M. Revenue was up 17.1% from 2023-12-31 to 2024-12-31. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
OPAL currently screens at market cap $318.1M and trailing P/E 26.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the OPAL and REGN stock pages for the full models.
Not investment advice.